1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Smith, J.W. Le Calvez, H. Parra-Gessert, L. Preece, N.E. Jia, X. Assa-Munt, N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 277 10298 10305 10.1074/jbc.M108071200 11748219 Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3. 2002 10.2210/pdb1i93/pdb pdb_00001i93 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1460.777 ION-SELECTIVE LIGAND D16 1 syn polymer no yes (ACE)CHWLRGDMRRC(NH2) XCHWLRGDMRRCX A polypeptide(L) n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-07-10 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id NMR Ensemble of Ion-Selective Ligand A1 for Platelet Integrin alphaIIb-beta3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 RCSB Y RCSB 2001-03-17 REL REL The peptide was chemically synthesized: Commercial solid phase with cyclization with selective disulphide oxidation sample THE ENSEMBLE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES (CIRCA 2000) structures with the lowest energy 200 15 NOESY & DQF-COSY 10mM PHOSPHATE/5% D2O 6.50 1 atm 278.00 K ENSEMBLE D16 IS BASED ON A TOTAL OF 74 NOE-DERIVED DISTANCE CONSTRAINTS, 9 DIHEDRAL ANGLE RESTRAINTS, 1 COVALENT CYS-SS-CYS BOND AND 1 LRGD, I, HYDROGEN BOND RESPECTIVELY. REFINEMENTS INCORPORATED ALPHA PROTON AND ALPHA, BETA CARBON SHIFTS OF 11 RESIDUES. RESTRAINED MOLECULAR DYNAMICS AND CHEMICAL SHIFT REFINEMENT. 3MG D16/ML BRUNGER A. NILGES M. (KUSZWESKI J. CLORE G.M.) refinement X-PLOR 3.8.5.1 (CHEM.SHIFT.MODULE) VARIANINC collection VNMR 6.1B HARE,D. > Biosym > MSI data analysis Felix 2000 500 Varian UNITYPLUS ACE 1 n 1 ACE 1 A CYS 2 n 2 CYS 2 A HIS 3 n 3 HIS 3 A TRP 4 n 4 TRP 4 A LEU 5 n 5 LEU 5 A ARG 6 n 6 ARG 6 A GLY 7 n 7 GLY 7 A ASP 8 n 8 ASP 8 A MET 9 n 9 MET 9 A ARG 10 n 10 ARG 10 A ARG 11 n 11 ARG 11 A CYS 12 n 12 CYS 12 A CYS 12 n 13 NH2 13 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 6 0.219 SIDE CHAIN 1 A ARG 10 0.315 SIDE CHAIN 1 A ARG 11 0.317 SIDE CHAIN 2 A ARG 6 0.279 SIDE CHAIN 2 A ARG 10 0.254 SIDE CHAIN 2 A ARG 11 0.216 SIDE CHAIN 3 A ARG 6 0.316 SIDE CHAIN 3 A ARG 10 0.215 SIDE CHAIN 3 A ARG 11 0.311 SIDE CHAIN 4 A ARG 6 0.308 SIDE CHAIN 4 A ARG 10 0.248 SIDE CHAIN 4 A ARG 11 0.250 SIDE CHAIN 5 A ARG 6 0.309 SIDE CHAIN 5 A ARG 10 0.307 SIDE CHAIN 5 A ARG 11 0.317 SIDE CHAIN 6 A ARG 6 0.288 SIDE CHAIN 6 A ARG 10 0.279 SIDE CHAIN 6 A ARG 11 0.264 SIDE CHAIN 7 A ARG 6 0.317 SIDE CHAIN 7 A ARG 10 0.311 SIDE CHAIN 7 A ARG 11 0.284 SIDE CHAIN 8 A ARG 6 0.243 SIDE CHAIN 8 A ARG 10 0.316 SIDE CHAIN 8 A ARG 11 0.229 SIDE CHAIN 9 A ARG 6 0.280 SIDE CHAIN 9 A ARG 10 0.306 SIDE CHAIN 9 A ARG 11 0.275 SIDE CHAIN 10 A ARG 6 0.266 SIDE CHAIN 10 A ARG 10 0.317 SIDE CHAIN 10 A ARG 11 0.315 SIDE CHAIN 11 A ARG 6 0.266 SIDE CHAIN 11 A ARG 10 0.303 SIDE CHAIN 11 A ARG 11 0.257 SIDE CHAIN 12 A ARG 6 0.237 SIDE CHAIN 12 A ARG 10 0.241 SIDE CHAIN 12 A ARG 11 0.284 SIDE CHAIN 13 A ARG 6 0.300 SIDE CHAIN 13 A ARG 10 0.289 SIDE CHAIN 13 A ARG 11 0.298 SIDE CHAIN 14 A ARG 6 0.300 SIDE CHAIN 14 A ARG 10 0.258 SIDE CHAIN 14 A ARG 11 0.316 SIDE CHAIN 15 A ARG 6 0.261 SIDE CHAIN 15 A ARG 10 0.291 SIDE CHAIN 15 A ARG 11 0.305 SIDE CHAIN 1 A LEU 5 -119.76 52.87 1 A ASP 8 -85.37 -149.96 2 A ASP 8 -90.45 -151.61 2 A ARG 10 -86.79 40.91 3 A ARG 6 43.35 27.31 3 A MET 9 -87.84 40.71 3 A ARG 10 -99.83 40.19 3 A ARG 11 -87.29 38.66 4 A TRP 4 -89.24 43.43 4 A MET 9 -64.44 88.81 4 A ARG 10 -89.50 49.25 5 A HIS 3 -90.16 -159.24 5 A ASP 8 -109.15 -148.88 6 A ARG 6 36.53 44.07 6 A MET 9 -100.12 48.62 7 A HIS 3 -93.31 50.13 7 A LEU 5 -116.65 -97.27 7 A ASP 8 -81.44 -151.23 8 A TRP 4 -91.26 45.37 8 A LEU 5 -100.03 42.76 8 A ASP 8 -109.60 -152.93 8 A MET 9 -69.01 91.92 8 A ARG 10 -86.07 48.80 9 A ASP 8 -78.01 -156.10 9 A MET 9 -69.54 89.12 10 A ARG 11 64.33 -76.17 11 A TRP 4 -102.67 47.89 11 A ARG 6 46.03 26.93 12 A LEU 5 -119.35 59.49 12 A ARG 6 52.40 19.98 12 A ASP 8 -84.28 -148.35 13 A TRP 4 -87.80 48.83 13 A ARG 6 59.73 14.07 13 A ASP 8 -85.87 -148.96 14 A HIS 3 -110.24 -156.78 15 A LEU 5 -113.97 -101.96 15 A ASP 8 -83.62 -155.79 15 A ARG 10 -81.22 42.14 15 A ARG 11 -95.38 49.67 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1 N N disulf 2.021 A CYS 2 A SG CYS 2 1_555 A CYS 12 A SG CYS 12 1_555 covale 1.306 both A ACE 1 A C ACE 1 1_555 A CYS 2 A N CYS 2 1_555 covale 1.304 both A CYS 12 A C CYS 12 1_555 A NH2 13 A N NH2 13 1_555 CELL ADHESION INTEGRIN, RGD, CELL ADHESION 1I93 PDB 1 1I93 1 13 1I93 1 13 1I93 A 1 1 13 BINDING SITE FOR RESIDUE ACE A 1 A ACE 1 Software 1 BINDING SITE FOR RESIDUE NH2 A 13 A NH2 13 Software 1 A HIS 3 A HIS 3 1 1_555 A CYS 12 A CYS 12 1 1_555 1 P 1